Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous Interventions

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Medicine

Background:

• Significant advancements in antithrombotic management exist for percutaneous interventions.
• Current evidence primarily stems from cardiac interventions, often leading to extrapolation to non-cardiac procedures.
• Differences in patient risk profiles and intervention types between cardiac and non-cardiac settings may affect antithrombotic therapy outcomes.

Purpose of the Study:

• To review and appraise existing evidence on antithrombotic therapy in patients undergoing non-cardiac percutaneous interventions.
• To highlight the specific challenges and considerations for high-bleeding-risk individuals in this context.
• To emphasize the importance of risk stratification in guiding clinical decisions for antithrombotic treatment.

Main Methods:

• Systematic review of available literature.
• Appraisal of evidence on antithrombotic strategies.
• Focus on studies involving non-cardiac percutaneous interventions.
• Analysis of outcomes in high-bleeding-risk patient populations.

Main Results:

• Most antithrombotic evidence is derived from cardiac interventions.
• Non-cardiac interventions frequently involve high-bleeding-risk patients.
• Extrapolation of cardiac regimens to non-cardiac settings may pose safety and efficacy concerns.

Conclusions:

• Antithrombotic therapy in non-cardiac percutaneous interventions requires distinct considerations compared to cardiac procedures.
• High bleeding risk in patients undergoing non-cardiac interventions significantly impacts outcomes.
• Risk stratification is crucial for optimizing antithrombotic treatment decisions in this population.